An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
KORU Medical Systems Appoints Brian Case As Chief Technology Officer
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary
KORU Medical Systems (NASDAQ: KRMD) has appointed Brian Case as its new Chief Technology Officer. With over 20 years in R&D, including roles at Fresenius Kabi and Cook Medical, Case will lead product development and innovation. He aims to enhance KORU's technology strategy to support a global drug delivery portfolio. CEO Linda Tharby expressed confidence in Case's ability to drive value through his extensive experience. This leadership change comes at a vital time for KORU, as it seeks to innovate in home infusion solutions.
Positive
Appointment of Brian Case as CTO expected to enhance product development.
Case brings over 20 years of R&D experience, including successful stints at Fresenius Kabi and Cook Medical.
His proven track record in innovation and technology strategy may strengthen KORU's market position.
Negative
None.
CHESTER, N.Y.--(BUSINESS WIRE)--
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of Brian Case, a veteran medical technology R&D leader with over 20 years of experience, as the Company’s new Chief Technology Officer. Mr. Case will lead product development and innovation as the Company defines and executes a technology strategy to support a global drug delivery portfolio.
“With his proven track record of value creation through R&D technology development, deployment of product development strategy, and merger and acquisition experience, we are confident Brian will be a catalyst to the KORU team,” said Linda Tharby, President and CEO. “Brian is a great fit, with his value system, large and small company background, experiences and passion for the patient. He will be instrumental as we continue to define and execute KORU Medical’s product and technology strategy. His experience with global product and process development from the definition of customer needs to global market commercialization will pave the way for the Company as we strengthen our technology roadmap to serve more patients, partners, and customers.”
Brian joins the KORU Medical Systems team with over 20 years of research and development experience. Most recently, he spent over 16 years at Fresenius Kabi, a global healthcare company specializing in lifesaving medicines and technologies, as Vice President, Research and Development. Mr. Case provided business and technical leadership for the Transfusion and Cell Technologies division to drive long-term product vitality and competitive advantage of the business and promote entry into new business areas. Prior to Fresenius Kabi, Mr. Case spent six years at Cook Medical, a medical device company, as R&D Program Manager, Advanced Research. While there, he managed a cross-functional team that developed and assessed new technologies to create a product portfolio to service the peripheral disease market. Mr. Case received his Master of Science in Engineering Management from the Rose-Hulman Institute of Technology, and his Bachelor of Science in Engineering Mechanics, from the University of Illinois. In addition, Mr. Case is an inventor on over 100 patents, a Licensed Professional Mechanical Engineer, and a Certified Project Management Professional.
“I’m honored to be joining KORU at such a transformational stage in the company’s journey,” said Brian Case. “This is such an exciting opportunity to help drive innovation and develop best-in-class infusion solutions to better serve our patient community. There is so much potential, and I can’t wait to get started.”
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.
What is the significance of Brian Case's appointment at KORU Medical Systems?
Brian Case's appointment as CTO is significant as he brings over 20 years of R&D experience, which is expected to enhance KORU Medical's product development and innovation efforts.
What experience does Brian Case have in the medical technology field?
Brian Case has over 20 years of experience in medical technology, including leadership roles at Fresenius Kabi and Cook Medical, focusing on R&D and strategic product development.
How might Brian Case's role impact KORU Medical Systems' future?
Brian Case's leadership in product development and technology strategy is expected to drive innovation and support KORU Medical's goals in the global drug delivery market.
Who is the new Chief Technology Officer of KORU Medical Systems?
The new Chief Technology Officer of KORU Medical Systems is Brian Case, who has a strong background in R&D and product development.
What is KORU Medical Systems known for?
KORU Medical Systems is known for developing innovative home infusion solutions, including the FREEDOM Syringe Infusion System.
